Anti-IL-23 (Tremfya) (Guselkumab biosimilar) mAb
Gecertificeerd

Anti-IL-23 (Tremfya) (Guselkumab biosimilar) mAb

Catalog #: 12-2003-100
Maat: 100 µg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Description

Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.

Host

• Humanized

Reactivity

Human

Clonality

• Monoclonal

Applications

ELISA

Purification

Purified from cell culture supernatant by affinity chromatography

Storage Conditions

Store at -20°C to -80°C (Avoid repeated freezing and thawing) .

Applications Notes

ELISA 1:5000-10000, FACS 1:100

Isotype

IgG1

Beschrijving

Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively blo

Specificaties

ProductnaamAnti-IL-23 (Tremfya) (Guselkumab biosimilar) mAb
Categorie
Beschikbare grootte100 µg
Catalogusnummer12-2003-100